Hello,

My question is if the accuracy in dosing of afrezza inhalation powder will be affected if a

patient incurred a common cold, and had symptoms such as mucus and phlegm or

strep/other?

It seems inhalation of afreza could become inhibited which would be problematic for

patients and a concern among doctors.

Would this render the drug potentially less accurate than a needle or insulin pump?


I would like to know if these concerns have been addressed by Mannkind.



Regards,